Calcimedica, Common Stock Stock Price Prediction
| CALC Stock | 2.78 0.03 1.07% |
Oversold Vs Overbought
30
Oversold | Overbought |
EPS Estimate Next Quarter (0.33) | Wall Street Target Price 17 | EPS Estimate Current Quarter (0.50) |
Using CalciMedica, Common hype-based prediction, you can estimate the value of CalciMedica, Common Stock from the perspective of CalciMedica, Common response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in CalciMedica, Common to buy its stock at a price that has no basis in reality. In that case, they are not buying CalciMedica, because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
CalciMedica, Common after-hype prediction price | USD 2.8 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
CalciMedica, |
CalciMedica, Common After-Hype Price Prediction Density Analysis
As far as predicting the price of CalciMedica, Common at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in CalciMedica, Common or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of CalciMedica, Common, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
CalciMedica, Common Estimiated After-Hype Price Volatility
In the context of predicting CalciMedica, Common's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on CalciMedica, Common's historical news coverage. CalciMedica, Common's after-hype downside and upside margins for the prediction period are 0.14 and 8.57, respectively. We have considered CalciMedica, Common's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
CalciMedica, Common is unstable at this time. Analysis and calculation of next after-hype price of CalciMedica, Common Stock is based on 3 months time horizon.
CalciMedica, Common Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as CalciMedica, Common is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CalciMedica, Common backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with CalciMedica, Common, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.47 | 5.77 | 0.02 | 0.14 | 8 Events / Month | 4 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.78 | 2.80 | 0.72 |
|
CalciMedica, Common Hype Timeline
CalciMedica, Common Stock is currently traded for 2.78. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of -0.14. CalciMedica, is expected to increase in value after the next headline, with the price projected to jump to 2.8 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 0.72%, whereas the daily expected return is currently at -0.47%. The volatility of related hype on CalciMedica, Common is about 1914.22%, with the expected price after the next announcement by competition of 2.64. Net Loss for the year was (34.36 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next expected press release will be in about 8 days. Check out CalciMedica, Common Basic Forecasting Models to cross-verify your projections.CalciMedica, Common Related Hype Analysis
Having access to credible news sources related to CalciMedica, Common's direct competition is more important than ever and may enhance your ability to predict CalciMedica, Common's future price movements. Getting to know how CalciMedica, Common's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how CalciMedica, Common may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DGII | Digi International | 1.22 | 9 per month | 1.26 | 0.14 | 3.54 | (2.48) | 12.64 | |
| LPCN | Lipocine | (0.41) | 5 per month | 4.71 | 0.04 | 7.08 | (6.20) | 24.60 | |
| ASUR | Asure Software | (0.55) | 9 per month | 3.13 | 0 | 5.27 | (3.76) | 19.48 | |
| PMNXF | Perseus Mining Limited | 0.00 | 0 per month | 2.88 | (0.01) | 3.95 | (4.92) | 16.43 | |
| MTX | Minerals Technologies | (2.27) | 10 per month | 1.29 | 0.04 | 2.46 | (2.49) | 11.90 | |
| LOMLF | Lion One Metals | 0.00 | 0 per month | 0.00 | (0.13) | 4.76 | (4.76) | 15.00 | |
| PAYO | Payoneer Global | (0.10) | 11 per month | 1.44 | 0.16 | 2.27 | (2.46) | 28.47 |
CalciMedica, Common Additional Predictive Modules
Most predictive techniques to examine CalciMedica, price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for CalciMedica, using various technical indicators. When you analyze CalciMedica, charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About CalciMedica, Common Predictive Indicators
The successful prediction of CalciMedica, Common stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as CalciMedica, Common Stock, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of CalciMedica, Common based on analysis of CalciMedica, Common hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to CalciMedica, Common's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to CalciMedica, Common's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | PB Ratio | 0.14 | 0.25 | 1.57 | 1.65 | Capex To Depreciation | 0.94 | 6.66 | 1.34 | 1.28 |
Story Coverage note for CalciMedica, Common
The number of cover stories for CalciMedica, Common depends on current market conditions and CalciMedica, Common's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that CalciMedica, Common is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about CalciMedica, Common's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
CalciMedica, Common Short Properties
CalciMedica, Common's future price predictability will typically decrease when CalciMedica, Common's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of CalciMedica, Common Stock often depends not only on the future outlook of the potential CalciMedica, Common's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CalciMedica, Common's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.5 M | |
| Cash And Short Term Investments | 11.2 M |
Complementary Tools for CalciMedica, Stock analysis
When running CalciMedica, Common's price analysis, check to measure CalciMedica, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CalciMedica, Common is operating at the current time. Most of CalciMedica, Common's value examination focuses on studying past and present price action to predict the probability of CalciMedica, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CalciMedica, Common's price. Additionally, you may evaluate how the addition of CalciMedica, Common to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |